IgG4-RD Research

Stay up to date on the latest news and information about IgG4-RD clinical trials and research.

Learn about clinical research studies

Explore ongoing clinical trials

Read the latest IgG4-RD research news

What is a Clinical Trial?

A clinical trial is a research study that tests a new drug or medical device in volunteers to determine the safety and efficacy of the treatment. Information and results from clinical trials are used by regulators, such as the Food and Drug Administration (FDA) in the United States, to determine if a treatment should be approved for use by the general public.

More detailed information about clinical trials can be found at:

Explore IgG4-RD Clinical Trials

There are several IgG4-Related Disease (IgG4-RD) clinical trials currently recruiting volunteer participants in the United States and other countries throughout the world. For more information about these studies, please visit ClinicalTrials.gov

IgG4ward! does not promote or encourage participation in specific clinical trials.

Latest IgG4-RD News & Research Updates

Find all the latest IgG4-RD research news updates here in one place. All the updates we share has been reviewed by our IgG4-RD expert board members, so you can be sure the information is not only relevant, but also derived from a credible source.

igg4ward logo

Introducing IgG4ward!: An Organization Created to Support Individuals Living with IgG4-Related Disease

Dr. John Stone, a Professor of Medicine at Harvard Medical School, and the Edward A. Fox Chair in Medicine at the Massachusetts General Hospital in…

zenas logo

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb

Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based therapies, today announced that it has entered…

the lancet rheumatology

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab

Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies, announces The Lancet Rheumatology has published…

Thank You to Our Sponsors!

We want to thank all individual contributors who have supported and continue to support IgG4ward!

}); });